These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19287101)
1. Screening for early pancreatic ductal adenocarcinoma: an urgent call! Lee MX; Saif MW JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. Urayama S World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695 [TBL] [Abstract][Full Text] [Related]
4. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers. Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085 [TBL] [Abstract][Full Text] [Related]
5. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771 [TBL] [Abstract][Full Text] [Related]
7. The need for effective pancreatic cancer detection and management: a biomarker-based strategy. Crawley AS; O'Kennedy RJ Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma. Wang S; Chen X; Tang M Tumour Biol; 2014 Sep; 35(9):9101-9. PubMed ID: 25027396 [TBL] [Abstract][Full Text] [Related]
9. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. Halbrook CJ; Lyssiotis CA Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003 [TBL] [Abstract][Full Text] [Related]
10. Early detection and screening of pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. Gonda TA; Saif MW JOP; 2011 Mar; 12(2):83-5. PubMed ID: 21386626 [TBL] [Abstract][Full Text] [Related]
11. Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008. Saif MW JOP; 2008 Jul; 9(4):398-402. PubMed ID: 18648129 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1: a marker for pancreatic cancer diagnosis. Tanase CP Expert Rev Mol Diagn; 2008 Jul; 8(4):395-404. PubMed ID: 18598222 [TBL] [Abstract][Full Text] [Related]
13. Identifying molecular markers for the early detection of pancreatic neoplasia. Goggins M Semin Oncol; 2007 Aug; 34(4):303-10. PubMed ID: 17674958 [TBL] [Abstract][Full Text] [Related]
15. Early detection of sporadic pancreatic cancer: summative review. Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254 [TBL] [Abstract][Full Text] [Related]
16. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment. Singh P; Srinivasan R; Wig JD Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas. Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554 [TBL] [Abstract][Full Text] [Related]
18. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170 [TBL] [Abstract][Full Text] [Related]
19. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. Yousaf MN; Chaudhary FS; Ehsan A; Suarez AL; Muniraj T; Jamidar P; Aslanian HR; Farrell JJ BMJ Open Gastroenterol; 2020 May; 7(1):. PubMed ID: 32414753 [TBL] [Abstract][Full Text] [Related]
20. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review. Abdallah R; Taly V; Zhao S; Pietrasz D; Bachet JB; Basile D; Mas L; Zaanan A; Laurent-Puig P; Taieb J Cancer Treat Rev; 2020 Jul; 87():102028. PubMed ID: 32485509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]